LUISETTI, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 4.297
EU - Europa 3.122
AS - Asia 2.067
AF - Africa 7
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
Totale 9.510
Nazione #
US - Stati Uniti d'America 4.284
CN - Cina 2.031
IE - Irlanda 918
UA - Ucraina 771
FI - Finlandia 457
DE - Germania 414
SE - Svezia 244
GB - Regno Unito 116
IT - Italia 97
FR - Francia 47
BE - Belgio 30
CA - Canada 13
IR - Iran 11
RU - Federazione Russa 9
IN - India 7
AU - Australia 6
CZ - Repubblica Ceca 5
EU - Europa 5
NL - Olanda 5
EG - Egitto 4
HK - Hong Kong 4
PK - Pakistan 4
MU - Mauritius 3
PT - Portogallo 3
SG - Singapore 3
AR - Argentina 2
BR - Brasile 2
JP - Giappone 2
LV - Lettonia 2
TR - Turchia 2
AT - Austria 1
AZ - Azerbaigian 1
CL - Cile 1
GR - Grecia 1
KR - Corea 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
TW - Taiwan 1
Totale 9.510
Città #
Jacksonville 954
Chandler 927
Dublin 917
Nanjing 639
Ashburn 278
Nanchang 230
Princeton 199
Lawrence 192
Shenyang 189
Wilmington 167
Hebei 163
Changsha 152
Beijing 148
Ann Arbor 147
Jiaxing 147
Boardman 109
Medford 101
Hangzhou 97
Helsinki 87
Tianjin 86
Woodbridge 51
Shanghai 50
Norwalk 37
Milan 36
Brussels 30
Falls Church 28
Houston 28
Fairfield 25
Kunming 25
Washington 25
New York 23
Verona 23
Des Moines 20
Dearborn 19
Seattle 19
Tappahannock 17
Pavia 9
Changchun 8
Fuzhou 8
Jinan 8
Auburn Hills 7
Lanzhou 7
Ningbo 7
Orange 7
Taizhou 7
Toronto 7
Zhengzhou 7
Berlin 5
Novara 5
San Francisco 5
Teplice 5
Karachi 4
Ottawa 4
Pune 4
Leawood 3
Lewiston 3
Lisbon 3
Los Angeles 3
Novokuznetsk 3
Redwood City 3
Rome 3
Sydney 3
Tomsk 3
Alexandria 2
Aversa 2
Borås 2
Cairo 2
Corsico 2
Durham 2
Falkenstein 2
Frisco 2
Melbourne 2
Nantes 2
Naples 2
Paraná 2
San Jose 2
São Paulo 2
Tehran 2
Torino 2
Zanjan 2
Amsterdam 1
Andover 1
Anqing 1
Asaka 1
Augusta 1
Bethesda 1
Bolzano 1
Burlington 1
Canberra 1
Chicago 1
Clonmel 1
Como 1
Doncaster 1
Edmond 1
Fayetteville 1
Framingham 1
Frankfurt am Main 1
Geislingen an der Steige 1
Gostar 1
Gravina In Puglia 1
Totale 6.580
Nome #
Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease. 200
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 100
Separation of closely related peptide substrates of human proteinases by micellar electrokinetic chromatography with anionic and nonionic surfactants. 88
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 87
Familial elevation of serum angiotensin converting enzyme activity. 86
Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis. 86
Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency. 82
Advances in proteomic techniques for biomarker discovery in COPD 81
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 80
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 73
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. 73
A national program for detection of alpha 1-antitrypsin deficiency in Italy. Gruppo I.D.A. 72
Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. 71
α₁-Antitrypsin level and pheno/genotypes 71
Studies of MR 889, a new synthetic proteinase inhibitor. 70
Identification and characterisation of eight novel SERPINA1 null mutations. 70
Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles. 69
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. 69
A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer. 69
Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease 67
alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. 67
A fast amplification-reverse hybridization assay kit to detect the most frequent deficient variants in the alpha-1-antitrypsin gene. 66
Alpha1-antitrypsin in serum determined by capillary isoelectric focusing 65
Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. 65
Some properties of the alkaline proteinase from Aspergillus melleus. 65
Alpha1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001. 64
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. 64
C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. 64
Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. 64
Study of functional and biochemical indicators of subclinical lung damage in bleomycin-treated patients. 63
Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease. 63
Assessment and management of pulmonary alveolar proteinosis in a reference center. 63
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. 62
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production 61
Micellar electrokinetic chromatography: a convenient alternative to colorimetric and high performance liquid chromatographic detection for monitoring protease activity. 61
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 61
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. 60
HLA markers in sarcoidosis. 60
The Rapid FEV(1) Decline in Chronic Obstructive Pulmonary Disease Is Associated with Predominant Emphysema: A Longitudinal Study. 60
Alpha-1 antitrypsin deficiency: from Italy to the world. 59
HLA and sarcoidosis: new pathogenetic insights. 58
Ambroxol and pulmonary toxicity induced by antineoplastic drugs. 58
Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis. 58
On the activity of MR 889, a new synthetic proteinase inhibitor. 58
Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency. 58
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. 57
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. 57
A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. 57
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 57
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 56
The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? 56
Inhibition of human neutrophil elastase by erythromycin andflurythromycin, two macrolide antibiotics. 55
Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: a critical review of the state-of-the-art. 55
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. 55
Interactions of alpha-1-antichymotrypsin, alpha-1-proteinase inhibitor, and alpha-2-macroglobulin with the fungal enzyme, seaprose. 55
HLA Class I, II and III polymorphisms in sarcoidosis. 55
Complement receptor 1 gene polymorphisms in sarcoidosis. 55
Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage. 55
The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. 55
Lung cancer in young adults. 54
Genetics of idiopathic disseminated bronchiectasis. 54
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 54
Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. 54
COPD: no gene left unturned 54
Micellar Electrokinetic Chromatography with Laser Induced Detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with Chronic Obstructive Pulmonary Disease: A comparative analysis. 54
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 54
Mechanisms of lung injury in cystic fibrosis. 53
In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages. 53
Report of one case of familial sarcoidosis. 53
In vivo studies of rat alveolar macrophage [corrected] microviscosity: influence of pulmonary surfactant synthesis stimulation. 53
Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence. 53
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 53
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. 52
Introduction: the history of the Alpha One International Registry (A.I.R.). 52
Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis. 52
Genetics of chronic obstructive pulmonary disease and disseminated bronchiectasis. 52
Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. 52
The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. 52
A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant. 52
Activity of different proteases in a complex mixture and 'in vitro' study of their reciprocal interferences by micellar electrokinetic chromatography. 52
Interactions of P 1507, a new antioxidant agent, with phagocyte functions. 51
Sarcoidosis of the thyroid: report of a case and a review of the literature. 51
Biochemical and functional markers of lung damage after bleomycin treatment. 51
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 51
A novel method for rapid genotypic identification of alpha 1-antitrypsin variants. 51
High performance capillary electrophoresis in the study of proteinase activity and of markers of lung destruction. 50
Clinical utility gene card for: α-1-antitrypsin deficiency. 50
NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. 50
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 50
[American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]. 50
Mapping the activities of secretory leukoprotease inhibitor. 49
Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. 49
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study. 49
Validation of a rapid, simple method to measure alpha1-antitrypsin in human dried blood spots. 49
Comment on 'CFTR gene mutations in sarcoidosis'. 49
Kruppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. 49
Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report. 49
Primary lung adenocarcinoma: characteristics by smoking habit and sex. 49
Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. 49
Capillary electrophoresis as a modern tool for determining proteolytic activities in purified specimens and in real samples 49
Totale 6.098
Categoria #
all - tutte 30.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201932 0 0 0 0 0 0 0 0 0 22 5 5
2019/20202.693 745 991 40 185 42 174 18 175 15 186 120 2
2020/20211.415 179 141 42 152 3 182 11 220 38 215 191 41
2021/2022727 18 5 5 16 17 26 22 60 49 10 126 373
2022/20232.658 284 184 19 225 319 276 0 153 1.061 22 71 44
2023/2024817 102 180 43 67 109 199 14 50 8 45 0 0
Totale 9.587